Loading

NORML Blog

  • by Allen St. Pierre, NORML Executive Director February 2, 2015

    Need another prime example of cannabis prohibition coming to pass in these United States? Look no further than the states of Alaska and Oregon where the voters have ended cannabis prohibition and instead replaced the failed prohibition with tax-n-regulate policies, both states are canceling the use (and expense) of maintaining and employing cannabis sniffing canines.pot_civil_rights

    Up next in states that have jettisoned cannabis prohibition: Canceling law enforcement overflights looking for once illegal cannabis plants.

     

     

  • by Keith Stroup, NORML Legal Counsel

    6_8_NORMLK.StroupPortrait_zThe drug warriors — led principally by law enforcement and their handmaidens in the state legislatures — continue to do everything within their power to prolong marijuana prohibition, even in those states in which the voters have approved full legalization.

    I am referring specifically to a legislative proposal introduced last week in the Alaska state legislature, allegedly to implement their recent legalization initiative, under which possession of one ounce of marijuana and the private cultivation of six plants was legalized for everyone over 21 years of age. Recreational marijuana use will be totally decriminalized effective February 24, although the state has until the end of the year to implement the regulations for licensing recreational growers and dispensaries.

    Senate Bill 30, and it’s House companion bill, HB 79, initially considered by the House and Senate Judiciary Committees last week, would have kept any amount of marijuana illegal, causing users to be arrested and brought to trial, when they could then raise an affirmative defense by proving they were over 21 and their conduct was protected under the new initiative.

    To read the balance of this column, please go to Marijuana.com.

     

  • by Paul Armentano, NORML Deputy Director January 26, 2015

    American Academy of Pediatrics Calls For Rescheduling CannabisAn updated policy statement issued today by the American Academy of Pediatrics (AAP) calls for the rescheduling of the cannabis plant under federal law to better facilitate clinical trial research and to promote the plant’s eventual pharmaceutical development.

    The new position statement resolves: “The AAP strongly supports research and development of pharmaceutical cannabinoids and supports a review of policies promoting research on the medical use of these compounds. The AAP recommends changing marijuana from a Drug Enforcement Administration schedule I (controlled substance) to a Schedule II drug to facilitate this (clinical) research.”

    By definition, schedule I controlled substances are defined as possessing no “accepted medical use.” Clinical protocols involving cannabis are strictly controlled and require authorization from various federal agencies, including DEA, FDA, and the National Institute on Drug Abuse (NIDA) – the latter of which is designated under federal law as the sole provider of cannabis and/or organic cannabinoids for research purposes.

    “A Schedule 1 listing means there’s no medical use or helpful indications, but we know that’s not true because there has been limited evidence showing [marijuana] may be helpful for certain conditions in adults,” said Dr. Seth Ammerman, who co-authored the new policy statement.

    The newly amended AAP resolution also acknowledges that certain types of cannabinoid-therapy may provide benefits to adolescents, particularly those patient populations with treatment-resistant forms of epilepsy and chronic seizures. It states, “The AAP recognizes that marijuana may currently be an option for cannabinoid administration for children with life-limiting or severely debilitating conditions and for whom current therapies are inadequate.”

    Last year the Epilepsy Foundation of America issued a similar resolution, citing preclinical data and observational reports of the potential therapeutic benefit of the cannabinoid cannabidiol (CBD) in pediatric patients and calling for “an end to Drug Enforcement Administration (DEA) restrictions that limit clinical trials and research into medical marijuana for epilepsy.”

    Separate language in the AAP’s position statement also addresses the social use of the plant, affirming, “AAP strongly supports the decriminalization of marijuana use for both minors and young adults and encourages pediatricians to advocate for laws that prevent harsh criminal penalties for possession or use of marijuana.” By contrast, the statement acknowledges the group’s continued opposition to the legalization of marijuana, a policy change that it alleges poses “potential harm to children.”

    Text of the amended AAP position paper is online here. A summary of resolutions issued by other medical and health organizations in regard to patient access to therapeutic cannabis is available on the NORML website here.

  • by Keith Stroup, NORML Legal Counsel

    marijuana legalizationYou don’t have to look too hard to see marijuana legalization efforts in several states that have a good chance of being approved by the voters in 2016. But many of those efforts are mired-down with competing proposals and competing proponents that could easily undermine the ability of supporters in those states to actually change public policy and end prohibition.

    The inability to accept compromise in the interest of building a winning coalition threatens to turn some of these political opportunities into losing efforts. And that would be a disaster.

    Specifically, different factions with different political demands are competing for control of the issue in Massachusetts, Ohio and California, three large and important states that would add enormous legitimacy and political credibility to the legalization movement, were they to approve legalization in 2016.

    Click here to read the balance of this column.

  • by Keith Stroup, NORML Legal Counsel January 19, 2015

    Want Legalization in Your State?How do we move from prohibition to legalization in my state?

    That’s one of the most asked questions we hear every week at NORML.

    With national media attention focusing on the favorable experience with legalization in Colorado and Washington, and on the not-yet-implemented legalization programs recently adopted in Oregon and Alaska, anyone living in a state that continues arresting and jailing marijuana smokers would naturally wonder why their state seems to have missed out on the drive to end marijuana prohibition.

    More accurately, many of those states are lagging behind in the legalization movement, but that, too, will change. As we continue to gather data demonstrating these new laws are working as intended, with few unintended consequences, the drive to end marijuana prohibition will soon reach every state in the union, and beyond. We are no longer debating theory and conjecture; we now have real-life experiences that can be evaluated, and that data resource will grow with each new state.

    Patience and persistence still required

    We all need to accept the reality that changing public policy is a complex process that requires financial resources, re-education and political organizing. Following more than 75 years of criminal prohibition, and “reefer madness” propaganda by our state and federal governments, many Americans — especially older Americans — hold a negative view of marijuana and marijuana smoking, believing it presents a risk to health or public safety.

    Since all but a few of us have lived under prohibition for our entire lives, it is understandable that many would presume there must have been some justification for those tens of millions of marijuana arrests. Surely our own government would not needlessly wreak havoc on all those lives and careers without a good reason.

    To Read the Balance of This Column, please go to Marijuana.com.

Page 4 of 347« First...23456...102030...Last »